Company Overview and News

 
Sreeleathers Limited - Shareholders meeting

2017-11-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Mahindra & Mahindra Limited - Acquisition

2017-11-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Zecotek Proposes to Extend Warrants

2017-11-30 marketwired
SINGAPORE--(Marketwired - November 29, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS) (FRANKFURT: W1I),a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, today announced that it proposes to amend the terms of 3,084,000 warrants issued to subscribers in a private placement which closed on December 15, 2015. The Company proposes to extend the expiry date from December 15, 2017 to December 15, 2018.
Upvote Downvote

 
Liberty One Announces $5 Million Financing

2017-11-30 marketwired
VANCOUVER, BC--(Marketwired - Nov 29, 2017) - Liberty One Lithium Corp. (TSX VENTURE: LBY) (OTCQB: LRTTF) (FRANKFURT: L1T)
Upvote Downvote

 
ICC International Cannabis Corporation Files Financial Results for the Third Quarter Ended September 30, 2017

2017-11-30 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 29, 2017) - ICC International Cannabis Corporation ("ICC" or the "Company") (TSX VENTURE:ICC), a fully licensed producer and distributor in Uruguay of cannabis products, including cannabinoid extracts used for medicinal purposes and recreational cannabis, is pleased to announce it has filed its interim financial results for the third quarter ended September 30, 2017.
Upvote Downvote

 
Tata Communications Limited - Press Release

2017-11-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
New York & Company's (NWY) CEO Greg Scott on Q3 2017 Results - Earnings Call Transcript

2017-11-30 seekingalpha
Good day, ladies and gentlemen. And welcome to today’s New York & Company Third Quarter Fiscal Year 2017 Earnings Call. As a reminder, today’s conference is being recorded.
Upvote Downvote

 
Wow Unlimited Media Announces Financial Results for the Third Quarter of 2017

2017-11-30 marketwired
VANCOUVER, BC--(Marketwired - November 29, 2017) - Wow Unlimited Media Inc. (formerly Rainmaker Entertainment Inc.) ("Wow" or the "Company") (TSX VENTURE: WOW.A)(TSX VENTURE: WOW.B) announced its results for the three and nine months ended September 30, 2017.
Upvote Downvote

 
Monster Digital, Inc. Provides Update Regarding Anticipated Closing Date for Merger with Innovate Biopharmaceuticals, Inc.

2017-11-30 marketwired
SIMI VALLEY, CA--(Marketwired - Nov 29, 2017) - Monster Digital, Inc. (NASDAQ: MSDI) ("Monster Digital" or the "Company") announced today that the Company and Innovate Biopharmaceuticals, Inc. ("Innovate") have agreed to work towards the closing (the "Closing") of the proposed reverse merger ("Merger") between Monster Digital and Innovate on or before December 19, 2017. 
Upvote Downvote

 
LED Medical Diagnostics Announces Consolidation of Shares on 10 for 1 Basis

2017-11-30 accesswire
VANCOUVER, BC / ACCESSWIRE / November 29, 2017 / LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX-V: LMD; OTCQB: LEDIF; FSE: LME) is pleased to announce that the TSX Venture Exchange has approved the consolidation of its common shares on a 10 for 1 basis. The consolidation will take effect at the open of market on Thursday, November 30, 2017. Assuming no other change in the issued capital of the Company, it is expected that upon completion of the consolidation LED will have approximately 37,914,637 common shares issued and outstanding, reduced from 379,146,372 common shares that are currently issued and outstanding.
Upvote Downvote

 
Beleave Aims to Raise Awareness by Supporting Don't Drive High Campaign

2017-11-30 marketwired
TORONTO, ONTARIO--(Marketwired - Nov. 29, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(CSE:BE.CN)(CSNX:BE)(OTCQX:BLEVF) is pleased to support initiatives like the "Don't Drive High" campaign that make the public aware of the potential repercussions to driving under the influence. As we get closer to the legalization of recreational cannabis in Canada in July 2018, Ontario is planning on introducing tougher penalties for drivers caught under the influence.
Upvote Downvote

 
Cumulus Enters Restructuring Support Agreement to Reduce Debt by Over $1 Billion OTC Markets:CMLS

2017-11-30 globenewswire
ATLANTA, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (OTCQX:CMLS) (the “Company,” “we,” “us,” or “our”) today announced that it has entered into a Restructuring Support Agreement (the “RSA”) with, among others, certain of its secured lenders, holding in the aggregate, approximately 69% of the Company’s term loan to reduce the Company’s debt by more than $1 billion. To implement the balance sheet restructuring contemplated by the RSA, the Company today filed voluntary petitions for reorganization under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York.
Upvote Downvote

 
Marathon Oil announces $1-billion gross debt reduction

2017-11-30 worldoil
HOUSTON -- Marathon Oil Corporation has announced that it has entered into a transaction to redeem at par the outstanding $1 billion of 5.125% municipal revenue bonds due in 2037. This transaction will reduce gross debt by $1 billion and annual cash interest expense by $51 million while preserving the ability to remarket up to $1 billion of the tax-exempt municipal bonds to third parties between closing and the maturity date of 2037.
Upvote Downvote

 
Revive Therapeutics Announces Results for the Three Months Ended September 30, 2017

2017-11-30 marketwired
TORONTO, ONTARIO--(Marketwired - Nov. 29, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors, today announced its results for the three months ended September 30, 2017. The unaudited condensed interim consolidated financial statements and related interim management's discussion and analysis for the three months ended September 30, 2017 may be viewed on SEDAR at www.
Upvote Downvote

 
Automotive Finco Corp. Files Condensed Interim Consolidated Financial Statements for the Seven Months Ended September 30, 2017

2017-11-30 marketwired
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. THIS NEWS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY OF THE SECURITIES IN THE UNITED STATES.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...